Topic Hub
28 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 28 of 28 clinical reviews.
How to verify your commercial or employer insurance covers GLP-1 medications, lab work, and telehealth visits before enrolling in a weight-management program like Calibrate or HealthRX.
Read clinical reviewGLP-1 receptor agonists like semaglutide and liraglutide show early neuroprotective signals that may benefit menopause-related brain fog. Here is what the clinical evidence actually says.
Read clinical reviewFind out whether Aetna covers Lantus (insulin glargine), what you can expect to pay out of pocket, prior authorization requirements, and lower-cost alternatives on Aetna formularies.
Read clinical reviewFind out whether Amerigroup covers Jardiance (empagliflozin), what formulary tier to expect, prior authorization requirements, and how to lower your out-of-pocket cost.
Read clinical reviewFind out whether Amerigroup covers Novolog (insulin aspart), what tier it sits on, prior authorization requirements, copay ranges, and how to appeal a denial.
Read clinical reviewFind out whether Anthem Blue Cross Blue Shield covers Lantus (insulin glargine), what formulary tier it falls on, prior authorization requirements, copay ranges, and lower-cost biosimilar alternatives.
Read clinical reviewFind out whether Blue Cross Blue Shield of Alabama covers Jardiance (empagliflozin), including formulary tier placement, prior authorization requirements, copay ranges, and tips to lower your out-of-pocket cost.
Read clinical reviewFind out whether Blue Cross Blue Shield of Alabama covers Novolog (insulin aspart), including formulary tier placement, copay ranges, prior authorization requirements, and lower-cost alternatives.
Read clinical reviewFind out whether Blue Cross Blue Shield of Arizona covers Lantus (insulin glargine), what formulary tiers apply, prior authorization requirements, and how to reduce your out-of-pocket costs.
Read clinical reviewFind out whether Blue Cross Blue Shield of Massachusetts covers Farxiga (dapagliflozin), including formulary tier, prior authorization requirements, and cost-saving alternatives.
Read clinical reviewFind out whether Blue Cross Blue Shield of Massachusetts covers Januvia (sitagliptin), what formulary tier it falls on, prior authorization requirements, copay estimates, and lower-cost alternatives for type 2 diabetes.
Read clinical reviewFind out whether Blue Cross Blue Shield of Massachusetts covers Lantus (insulin glargine), including formulary tier placement, copay estimates, biosimilar alternatives, and step-therapy requirements.
Read clinical reviewFind out whether Blue Cross Blue Shield of Massachusetts covers Novolog (insulin aspart), what formulary tiers apply, prior authorization requirements, and how to reduce your out-of-pocket costs.
Read clinical reviewFind out whether Blue Cross Blue Shield of Michigan covers Lantus (insulin glargine), including formulary tier placement, prior authorization requirements, copay estimates, and how to access affordable insulin in Michigan.
Read clinical reviewFind out whether Blue Cross Blue Shield of Minnesota covers Januvia (sitagliptin), including formulary tier placement, prior authorization requirements, copay estimates, and covered alternatives.
Read clinical reviewFind out whether Blue Cross Blue Shield of Minnesota covers Novolog (insulin aspart), including formulary tiers, copay estimates, prior authorization requirements, and cost-saving alternatives.
Read clinical reviewFind out whether Blue Cross Blue Shield of Texas covers Farxiga (dapagliflozin), what tier it sits on, prior authorization requirements, and how to lower your out-of-pocket cost.
Read clinical reviewFind out whether BCBSTX covers Lantus (insulin glargine), what tier it sits on, prior authorization rules, biosimilar alternatives, and how to reduce your out-of-pocket cost.
Read clinical reviewFind out whether Blue Cross Blue Shield of Texas covers Novolog (insulin aspart), including formulary tier placement, copay ranges, prior authorization rules, and lower-cost alternatives.
Read clinical reviewPCOS is the most common cause of hirsutism in women. Learn how androgen excess drives unwanted hair growth, what treatments work, and when to see a specialist.
Read clinical reviewEvidence-based review of turmeric and curcumin for weight loss, including clinical trial data on BMI, waist circumference, and body fat, plus dosing and safety guidance.
Read clinical reviewLearn how polycystic ovary syndrome (PCOS) is diagnosed, including the Rotterdam criteria, key signs and symptoms, blood tests, ultrasound findings, and what to expect during evaluation.
Read clinical reviewEvidence-based fueling strategies for runners over 40 who practice intermittent fasting. Covers glycogen timing, protein needs, hormonal shifts, and blood sugar management during midlife training.
Read clinical reviewLow libido can signal diabetes, cardiovascular disease, hormonal deficiency, or depression. Learn what the research says about sexual desire as an early health marker and evidence-based ways to restore it.
Read clinical reviewPCOS affects 8-13% of reproductive-age women and raises the risk of type 2 diabetes, cardiovascular disease, infertility, and endometrial cancer. Here is what the clinical data actually says about severity.
Read clinical reviewGlipizide is a sulfonylurea prescribed for type 2 diabetes. Learn how it works, standard dosing, side effects, hypoglycemia risk, and how it compares to newer agents like metformin and GLP-1 agonists.
Read clinical reviewCompound lifts like squats, deadlifts, and rows recruit the most muscle mass per rep, driving greater glucose uptake, insulin sensitivity, and long-term metabolic improvement. Here is the clinical evidence behind this training strategy.
Read clinical reviewBlood pressure often rises during menopause due to estrogen decline, vascular stiffness, and metabolic shifts. Learn evidence-based causes and relief strategies.
Read clinical review